Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters.
Humans
Cytochrome P-450 CYP3A
/ metabolism
Glucuronides
Luteolin
/ pharmacology
Serum Albumin, Human
/ metabolism
Sulfates
/ metabolism
Organic Anion Transporters
/ metabolism
Cytochrome P-450 Enzyme System
/ metabolism
Flavonoids
/ pharmacology
Cytochrome P-450 CYP2C9
/ metabolism
Cytochrome P-450 CYP2C19
/ metabolism
Cytochrome P450 enzymes
Human serum albumin
Luteolin
Naringenin
OATP transporters
Sulfate/glucuronide metabolites
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
07
10
2022
revised:
28
11
2022
accepted:
02
12
2022
pubmed:
9
12
2022
medline:
15
12
2022
entrez:
8
12
2022
Statut:
ppublish
Résumé
Luteolin and naringenin are flavonoids found in various foods/beverages and present in certain dietary supplements. After a high intake of these flavonoids, their sulfate and glucuronide conjugates reach micromolar concentrations in the bloodstream. Some pharmacokinetic interactions of luteolin and naringenin have been investigated in previous studies; however, only limited data are available in regard to their metabolites. In this study, we aimed to investigate the interactions of the sulfate and glucuronic acid conjugates of luteolin and naringenin with human serum albumin, cytochrome P450 (CYP2C9, 2C19, and 3A4) enzymes, and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. Our main findings are as follows: (1) Sulfate conjugates formed more stable complexes with albumin than the parent flavonoids. (2) Luteolin and naringenin conjugates showed no or only weak inhibitory action on the CYP enzymes examined. (3) Certain conjugates of luteolin and naringenin are potent inhibitors of OATP1B1 and/or OATP2B1 enzymes. (4) Conjugated metabolites of luteolin and naringenin may play an important role in the pharmacokinetic interactions of these flavonoids.
Identifiants
pubmed: 36481402
pii: S0753-3322(22)01467-6
doi: 10.1016/j.biopha.2022.114078
pii:
doi:
Substances chimiques
Cytochrome P-450 CYP3A
EC 1.14.14.1
Glucuronides
0
Luteolin
KUX1ZNC9J2
Serum Albumin, Human
ZIF514RVZR
Sulfates
0
Organic Anion Transporters
0
Cytochrome P-450 Enzyme System
9035-51-2
Flavonoids
0
CYP2C9 protein, human
EC 1.14.13.-
Cytochrome P-450 CYP2C9
EC 1.14.13.-
CYP2C19 protein, human
EC 1.14.14.1
Cytochrome P-450 CYP2C19
EC 1.14.14.1
CYP3A4 protein, human
EC 1.14.14.55
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114078Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest statement The authors declare no competing interests.